High expression levels may be an intrinsic feature of the cell type, or due to promoter translocations between ABCB1 and genes with strong constitutive expression, such as those found in patients with breast or ovarian cancer who relapse after prior therapy (29, 30). This evidence concerns the gene ABCB1 and ovarian cancer.